Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 3, 2004, Pages 803-808

  Panburana, Panyu ^a   Sirinavin, Sayomporn ^a   Phuapradit, Winit ^a   Vibhagool, Asda ^a   Chantratita, Wasun ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cesarean delivery; HIV 1; Lamivudine; Perinatal prophylaxis; Zidovudine

Indexed keywords

DARBAZINE; LAMIVUDINE PLUS ZIDOVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BREAST FEEDING; CESAREAN SECTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; SHORT COURSE THERAPY; SIDE EFFECT; TABLET; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 1642423620     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.09.034     Document Type: Article

References (22)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sillivan MJ, et al, for the Pediatric AIDS Clinical Trial Group Protocol 076 Study Group. Reduction of mother-to-child transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. Shaffer N, Chuachoowong R, Mock PA, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999;353:773-80.
3. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996;335:1621-9.
4. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. J Am Med Assoc 1996;275:599-605.
5. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA III, Whitehouse J, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine: Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999;341:385-93.
6. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission: Women and Infants Transmission Study Group. N Engl J Med 1999;341:394-402.
7. Cooper ER, Charurat M, Mofenson L, Hanson C, Pitt J, Diaz C, et al, for the Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-94.
8. Katlama C, Ingrand D, Loveday C, Clumeck N, Mallolas J, Staszewski S, et al, for the Lamivudine European HIV Working Group. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naïve patients: a randomized controlled comparison with zidovudine monotherapy. JAMA 1996;276: 118-25.
9. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, et al. Lamivudine-zidovudine combination for prevention of mother-to-child transmission of HIV-1. JAMA 2001;285:2083-93.
10. Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, Vanprapar N, Sirimai K, Chearskul S, et al. Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. Clin Infect Dis 2002;35:1405-13.
11. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178-86.
12. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intra-partum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003;187:725-35.
13. The European Mode of Delivery Collaboration. Elective cesarean delivery versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999;353:1037-9.
14. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999;340:977-87.
15. Phuapradit W, Panburana P, Buamuenvai J. Simplified disposable abdominal and vulvar drapes for cesarean delivery in maternal HIV-1 infection. Int J Gynaecol Obstet 2000;70:373-5.
16. Bryson YJ, Luzusiaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992;327:1246-7.
17. StataCorp 2001. Stata statistical software: Release 7.0. College Station, Texas: Stata Corporation.
18. Ekpini RA, Nkengasong JN, Sibailly T, Maurice C, Adje C, Monga BB, et al. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS 2002;16:625-30.
19. Biggar RJ, Pahwa S, Minkoff H, Mendes H, Willoughby A, Landesman S, et al. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol 1989;161:1239-44.
20. Sirinavin S, Phuapradit W, Taneepanichskul S, Atamasirikul K, Hetrakul P, et al. Effect of immediate neonatal zidovudine on prevention of vertical transmission of human immunodeficiency virus type 1. Int J Infect Dis 2000;4:148-52.
21. Marcollet A, Goffinet F, Firtion G, Pannier E, Le Bret T, Brival ML, et al. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 2002;186:784-9.
22. Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, et al, for the Pediatrics AIDS Clinical Trials Group 288 Protocol Team. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr 2003;32:170-81.